Clinical Trials Logo

Combinational Immunotherapy clinical trials

View clinical trials related to Combinational Immunotherapy.

Filter by:
  • None
  • Page 1

NCT ID: NCT05031949 Recruiting - Clinical trials for Hepatocellular Carcinoma Non-Resectable

Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma

CCGLC-003
Start date: October 30, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to explore the efficacy and safety of hyperbaric oxygen therapy plus Camrelizumab as a second-line treatment in patients with advanced hepatocellular carcinoma who have failed at least 1 previous treatment.

NCT ID: NCT03895970 Completed - Cholangiocarcinoma Clinical Trials

Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors

Start date: April 20, 2019
Phase: Phase 2
Study type: Interventional

The investigators design a phase IIB clinical study to explore the efficacy and safety of lenvatinib plus pembrolizumab as a second-line treatment in patients with advanced hepatobiliary malignant tumors and to analyze potential biomarkers of therapeutic response.